Innovative Health, Llc

Innovative Health, LLC specializes in the reprocessing of single-use electrophysiology medical devices, primarily for the cardiology sector, delivering cost-effective alternatives designed to enhance patient safety and operational efficiency for healthcare providers. Founded in 2014, Innovative Health, LLC is based in Scottsdale, US, focusing on reprocessing single-use electrophysiology medical devices. The company was acquired by Driehaus Private Equity in August 2017, with undisclosed financial terms. Kevin MacDonald is the founder and Rick Ferreira serves as the CEO.

Innovative Health specializes in the reprocessing of single-use electrophysiology (EP) medical devices, primarily targeting the cardiology sector. The company’s flagship offerings include FDA-cleared reprocessed mapping catheters, diagnostic catheters, and other complex electrophysiology devices. These reprocessed devices significantly reduce the costs associated with cardiac procedures, such as those for Atrial Fibrillation (AFib), while ensuring patient safety and efficacy. Innovative Health’s products are designed for use in hospitals and electrophysiology labs across the United States, providing healthcare providers with a cost-effective alternative to new devices without compromising quality or performance.

The company has established itself as a partner for hospitals facing financial constraints, delivering solutions that enhance operational efficiencies and support improved patient care. Innovative Health generates revenue through the sale of reprocessed medical devices to healthcare facilities, primarily hospitals and electrophysiology labs, using a business-to-business (B2B) transaction model. Hospitals purchase reprocessed devices at reduced costs compared to new counterparts, achieving significant savings per procedure due to the proprietary reprocessing technology utilized by Innovative Health. The company’s pricing strategy reflects substantial discounts, allowing hospitals to optimize their budgets and invest in new technologies, expanding patient access to advanced care.

Innovative Health is focused on expanding its product line and geographic reach following its acquisition. The company is exploring new products aimed at enhancing its existing offerings, with potential release dates for new devices forthcoming. Additionally, it plans to expand into new markets, specifically targeting broader regions within the United States to increase its market share by 2025. The recent acquisition funding will be directed towards supporting these initiatives, enhancing product development and market expansion efforts.